GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Marketable Securities

ME Therapeutics Holding (XCNQ:METX) Marketable Securities : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ME Therapeutics Holding's Marketable Securities for the quarter that ended in Feb. 2024 was C$0.00 Mil.


ME Therapeutics Holding Marketable Securities Historical Data

The historical data trend for ME Therapeutics Holding's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Marketable Securities Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Marketable Securities
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Marketable Securities Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


ME Therapeutics Holding  (XCNQ:METX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


ME Therapeutics Holding Marketable Securities Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines